Surface Modification of Lipid-Based Nanocarriers: A Potential Approach to Enhance Targeted Drug Delivery

被引:73
|
作者
Priya, Sakshi [1 ]
Desai, Vaibhavi Meghraj [1 ]
Singhvi, Gautam [1 ]
机构
[1] Birla Inst Technol & Sci BITS Pilani, Dept Pharm, Ind Res Lab, Pilani 333031, Rajasthan, India
来源
ACS OMEGA | 2023年 / 8卷 / 01期
关键词
ORAL DELIVERY; MODIFIED ETHOSOMES; MODIFIED LIPOSOMES; CARRIERS NLC; NANOPARTICLES; CHITOSAN; DOCETAXEL; NANOEMULSION; CUBOSOMES; SYSTEMS;
D O I
10.1021/acsomega.2c05976
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Nanocarriers have the utmost significance for advancements in drug delivery and nanomedicine technology. They are classified as polymer-based nanocarriers, lipid-based nanocarriers, viral nanoparticles, or inorganic nanoparticles, depending on their constituent parts. Lipid-based nanocarrier systems have gained tremendous attention over the years because of their noteworthy properties like high drug-loading capacity, lower toxicity, better bioavailability and biocompatibility, stability in the gastrointestinal tract, controlled release, simpler scale-up, and validation process. Nanocarriers still have some disadvantages like poor drug penetration, limited drug encapsulation, and poor targeting. These disadvantages can be overcome by their surface modification. Surface-modified nanocarriers result in controlled release, enhanced penetration efficiency, and targeted medication delivery. In this review, the authors summarize the numerous lipid based nanocarriers and their functionalization through various surface modifiers such as polymers, ligands, surfactants, and fatty acids. Recent examples of newly developing surface-modified lipid-based nanocarrier systems from the available literature, along with their applications, have been compiled in this work.
引用
收藏
页码:74 / 86
页数:13
相关论文
共 50 条
  • [41] Recent Advances in Lipid-Based Drug Delivery
    Nishida, Koyo
    PHARMACEUTICS, 2021, 13 (07)
  • [42] Lipid-Based Nanoparticles as a Potential Delivery Approach in the Treatment of Rheumatoid Arthritis
    Chuang, Shih-Yi
    Lin, Chih-Hung
    Huang, Tse-Hung
    Fang, Jia-You
    NANOMATERIALS, 2018, 8 (01):
  • [43] Lipid-based nanocarriers: an attractive approach for rheumatoid arthritis management
    Zewail, Moataz B.
    Doghish, Ahmed S.
    El-Husseiny, Hussein M.
    Mady, Eman A.
    Mohammed, Osama A.
    Elbadry, Abdullah M. M.
    Elbokhomy, Amir S.
    Bhnsawy, Abdelmenem
    El-Dakroury, Walaa A.
    BIOMATERIALS SCIENCE, 2024, 12 (24) : 6163 - 6195
  • [44] Lipid-Based Nanovesicular Drug Delivery Systems
    Limongi, Tania
    Susa, Francesca
    Marini, Monica
    Allione, Marco
    Torre, Bruno
    Pisano, Roberto
    di Fabrizio, Enzo
    NANOMATERIALS, 2021, 11 (12)
  • [45] Lipid-based microtubular drug delivery vehicles
    Meilander, NJ
    Yu, XJ
    Ziats, NP
    Bellamkonda, RV
    JOURNAL OF CONTROLLED RELEASE, 2001, 71 (01) : 141 - 152
  • [46] Lipid-based nanocarriers for delivery of small interfering RNA for therapeutic use
    Parashar, Deepti
    Rajendran, Vinoth
    Shukla, Ravi
    Sistla, Ramakrishna
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 142
  • [47] Lipid-based colloidal carriers for targeted siRNA delivery
    Colombo, Stefano
    Foged, Camilla
    THERAPEUTIC DELIVERY, 2012, 3 (11) : 1245 - 1247
  • [48] Topical Drug Delivery of Anti-infectives Employing Lipid-Based Nanocarriers: Dermatokinetics as an Important Tool
    Thakur, Kanika
    Sharma, Gajanand
    Singh, Bhupindar
    Katare, Om Prakash
    CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (43) : 5108 - 5128
  • [49] Polymer-lipid hybrid systems: merging the benefits of polymeric and lipid-based nanocarriers to improve oral drug delivery
    Rao, Shasha
    Prestidge, Clive A.
    EXPERT OPINION ON DRUG DELIVERY, 2016, 13 (05) : 691 - 707
  • [50] Lipid-Based Nanocarriers for Lymphatic Transportation
    Vishwakarma, Nikhar
    Jain, Anamika
    Sharma, Rajeev
    Mody, Nishi
    Vyas, Sonal
    Vyas, Suresh P.
    AAPS PHARMSCITECH, 2019, 20 (02)